Fractyl Health financials
$0.5200+10.40%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 |
|---|---|---|
| Revenue | $0.00 | $93.0K |
| Gross profit | $0.00 | $43.0K |
| Gross margin | — | 46.2% |
| Operating income | -$96.8M | -$93.5M |
| Net income | -$141.0M | -$70.4M |
| Net margin | — | −75732.3% |
| Diluted EPS | $-1.86 | $-1.62 |
| EBITDA | -$95.7M | -$92.9M |
| Operating cash flow | -$90.3M | -$65.5M |
| Free cash flow | -$90.9M | -$67.3M |
| Diluted shares | 75.8M | 43.5M |
Balance sheet
| Period end | Dec 31 | Dec 31 |
|---|---|---|
| Cash & equivalents | $81.5M | $67.5M |
| Short-term investments | $0.00 | $0.00 |
| Total debt | $30.6M | $30.2M |
| Total assets | $121.4M | $108.1M |
| Total liabilities | $111.9M | $79.7M |
| Shareholders' equity | $9.5M | $28.4M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology